中国医药科学
中國醫藥科學
중국의약과학
CHINA MEDICINE AND PHARMACY
2014年
9期
183-185
,共3页
心脏起搏器%临床疗效%起搏参数
心髒起搏器%臨床療效%起搏參數
심장기박기%림상료효%기박삼수
Pacemaker%Clinical efficacy%Pacing parameter
目的：比较国产心脏起搏器Qingming 2312S/M型与百多力Axios S、圣犹达2402、美敦力RES01心脏起搏器的一般参数、起搏参数，分析国产心脏起搏器的临床疗效。方法随机选取我院2010年1月～2013年11月间安装心脏起搏器的患者100例作为观察对象，将其随机分为4组，每组25例，分别安置国产心脏起搏器Qinming 2312S/M、百多力Axios S、圣犹达2402、美敦力RES01起搏器，在患者术后即刻、术后3个月、6个月进行随访，记录起搏器的参数变化，比较各组起搏器的参数及功能。结果4组患者100%起搏理论寿命、50%起搏理论寿命差异无统计学意义（P＞0.05）；4组患者术后即刻、术后3个月、6个月起搏参数（阈值、阻抗、波幅）差异无统计学意义（P＞0.05）。结论国产心脏起搏器Qinming 2312S/M安全可靠，与进口心脏起搏器临床疗效无显著性差异。
目的：比較國產心髒起搏器Qingming 2312S/M型與百多力Axios S、聖猶達2402、美敦力RES01心髒起搏器的一般參數、起搏參數，分析國產心髒起搏器的臨床療效。方法隨機選取我院2010年1月～2013年11月間安裝心髒起搏器的患者100例作為觀察對象，將其隨機分為4組，每組25例，分彆安置國產心髒起搏器Qinming 2312S/M、百多力Axios S、聖猶達2402、美敦力RES01起搏器，在患者術後即刻、術後3箇月、6箇月進行隨訪，記錄起搏器的參數變化，比較各組起搏器的參數及功能。結果4組患者100%起搏理論壽命、50%起搏理論壽命差異無統計學意義（P＞0.05）；4組患者術後即刻、術後3箇月、6箇月起搏參數（閾值、阻抗、波幅）差異無統計學意義（P＞0.05）。結論國產心髒起搏器Qinming 2312S/M安全可靠，與進口心髒起搏器臨床療效無顯著性差異。
목적：비교국산심장기박기Qingming 2312S/M형여백다력Axios S、골유체2402、미돈력RES01심장기박기적일반삼수、기박삼수，분석국산심장기박기적림상료효。방법수궤선취아원2010년1월～2013년11월간안장심장기박기적환자100례작위관찰대상，장기수궤분위4조，매조25례，분별안치국산심장기박기Qinming 2312S/M、백다력Axios S、골유체2402、미돈력RES01기박기，재환자술후즉각、술후3개월、6개월진행수방，기록기박기적삼수변화，비교각조기박기적삼수급공능。결과4조환자100%기박이론수명、50%기박이론수명차이무통계학의의（P＞0.05）；4조환자술후즉각、술후3개월、6개월기박삼수（역치、조항、파폭）차이무통계학의의（P＞0.05）。결론국산심장기박기Qinming 2312S/M안전가고，여진구심장기박기림상료효무현저성차이。
Objective To compare the general parameters and pacing parameters of the domestic pacemaker Qingming 2312S/M to those of Biotronik Axios S, St. Jude 2402 and Medtronic RES01 and analyze the clinical efficacy of the domestic pacemaker. Methods One hundred patients who installed cardiac pacemaker in our hospital from January 2010 to November 2013 were selected as the observation subjects and randomly divided into 4 groups, with 25 patients in each group. The 4 groups installed the domestic pacemaker Qingming 2312S/M, Biotronik Axios S, St. Jude 2402 and Medtronic RES01 respectively. The patients received follow-up visits immediately after the surgery, 3 months after the surgery and 6 months after the surgery and the parameter changes of the pacemakers were recorded. The parameters and function of the pacemaker of each group were compared. Results The 100% pacing theoretical lifetime and the 50% pacing theoretical lifetime of the 4 groups of patients did not have statistically significant differences(P>0.05);The pacing parameters immediately after the surgery, 3 months after the surgery and 6 months after the surgery of the 4 groups of patients did not have statistically significant differences(P>0.05). Conclusion The domestic pacemaker Qingming 2312S/M is safe and reliable and its clinical efficacy is not significantly different from that of the imported cardiac pacemakers.
